New anticancer treatment

3 currently open clinical trials

A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Alpine Tumor Immunology Registry
SAKK 80/19 Alpine TIR
All cancer types